| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:GPHN-MPHOSPH8 |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: GPHN-MPHOSPH8 | FusionPDB ID: 34257 | FusionGDB2.0 ID: 34257 | Hgene | Tgene | Gene symbol | GPHN | MPHOSPH8 | Gene ID | 10243 | 54737 |
| Gene name | gephyrin | M-phase phosphoprotein 8 | |
| Synonyms | GEPH|GPH|GPHRYN|HKPX1|MOCODC | HSMPP8|TWA3|mpp8 | |
| Cytomap | 14q23.3-q24.1 | 13q12.11 | |
| Type of gene | protein-coding | protein-coding | |
| Description | gephyrin | M-phase phosphoprotein 8M-phase phosphoprotein, mppM-phase phosphoprotein, mpp8two hybrid-associated protein 3 with RanBPM | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q9NQX3 | Q99549 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000305960, ENST00000315266, ENST00000459628, ENST00000478722, ENST00000543237, ENST00000544752, | ENST00000496525, ENST00000361479, ENST00000414242, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 38 X 33 X 10=12540 | 25 X 17 X 10=4250 |
| # samples | 40 | 30 | |
| ** MAII score | log2(40/12540*10)=-4.97039353791468 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(30/4250*10)=-3.82442843541655 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: GPHN [Title/Abstract] AND MPHOSPH8 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | GPHN(66975309)-MPHOSPH8(20233135), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | GPHN-MPHOSPH8 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. GPHN-MPHOSPH8 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | GPHN | GO:0032324 | molybdopterin cofactor biosynthetic process | 26613940 |
| Hgene | GPHN | GO:0097112 | gamma-aminobutyric acid receptor clustering | 26613940 |
| Tgene | MPHOSPH8 | GO:0045814 | negative regulation of gene expression, epigenetic | 26022416|28581500|29211708 |
| Tgene | MPHOSPH8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing | 28581500|29211708 |
| Fusion gene breakpoints across GPHN (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across MPHOSPH8 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | MESO | TCGA-MQ-A6BQ-01A | GPHN | chr14 | 66975309 | + | MPHOSPH8 | chr13 | 20233135 | + |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000315266 | GPHN | chr14 | 66975309 | + | ENST00000414242 | MPHOSPH8 | chr13 | 20233135 | + | 2213 | 1185 | 1025 | 2212 | 396 |
| ENST00000315266 | GPHN | chr14 | 66975309 | + | ENST00000361479 | MPHOSPH8 | chr13 | 20233135 | + | 3776 | 1185 | 1025 | 2191 | 388 |
| ENST00000478722 | GPHN | chr14 | 66975309 | + | ENST00000414242 | MPHOSPH8 | chr13 | 20233135 | + | 2213 | 1185 | 1025 | 2212 | 396 |
| ENST00000478722 | GPHN | chr14 | 66975309 | + | ENST00000361479 | MPHOSPH8 | chr13 | 20233135 | + | 3776 | 1185 | 1025 | 2191 | 388 |
| ENST00000459628 | GPHN | chr14 | 66975309 | + | ENST00000414242 | MPHOSPH8 | chr13 | 20233135 | + | 1482 | 454 | 294 | 1481 | 395 |
| ENST00000459628 | GPHN | chr14 | 66975309 | + | ENST00000361479 | MPHOSPH8 | chr13 | 20233135 | + | 3045 | 454 | 294 | 1460 | 388 |
| ENST00000543237 | GPHN | chr14 | 66975309 | + | ENST00000414242 | MPHOSPH8 | chr13 | 20233135 | + | 1116 | 88 | 15 | 1115 | 366 |
| ENST00000543237 | GPHN | chr14 | 66975309 | + | ENST00000361479 | MPHOSPH8 | chr13 | 20233135 | + | 2679 | 88 | 15 | 1094 | 359 |
| ENST00000305960 | GPHN | chr14 | 66975309 | + | ENST00000414242 | MPHOSPH8 | chr13 | 20233135 | + | 1107 | 79 | 6 | 1106 | 366 |
| ENST00000305960 | GPHN | chr14 | 66975309 | + | ENST00000361479 | MPHOSPH8 | chr13 | 20233135 | + | 2670 | 79 | 6 | 1085 | 359 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000315266 | ENST00000414242 | GPHN | chr14 | 66975309 | + | MPHOSPH8 | chr13 | 20233135 | + | 0.002014537 | 0.9979855 |
| ENST00000315266 | ENST00000361479 | GPHN | chr14 | 66975309 | + | MPHOSPH8 | chr13 | 20233135 | + | 0.000895003 | 0.9991049 |
| ENST00000478722 | ENST00000414242 | GPHN | chr14 | 66975309 | + | MPHOSPH8 | chr13 | 20233135 | + | 0.002014537 | 0.9979855 |
| ENST00000478722 | ENST00000361479 | GPHN | chr14 | 66975309 | + | MPHOSPH8 | chr13 | 20233135 | + | 0.000895003 | 0.9991049 |
| ENST00000459628 | ENST00000414242 | GPHN | chr14 | 66975309 | + | MPHOSPH8 | chr13 | 20233135 | + | 0.001335092 | 0.99866486 |
| ENST00000459628 | ENST00000361479 | GPHN | chr14 | 66975309 | + | MPHOSPH8 | chr13 | 20233135 | + | 0.000501452 | 0.9994985 |
| ENST00000543237 | ENST00000414242 | GPHN | chr14 | 66975309 | + | MPHOSPH8 | chr13 | 20233135 | + | 0.000969734 | 0.99903023 |
| ENST00000543237 | ENST00000361479 | GPHN | chr14 | 66975309 | + | MPHOSPH8 | chr13 | 20233135 | + | 0.000387458 | 0.9996126 |
| ENST00000305960 | ENST00000414242 | GPHN | chr14 | 66975309 | + | MPHOSPH8 | chr13 | 20233135 | + | 0.001006155 | 0.9989938 |
| ENST00000305960 | ENST00000361479 | GPHN | chr14 | 66975309 | + | MPHOSPH8 | chr13 | 20233135 | + | 0.000407605 | 0.99959236 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >34257_34257_1_GPHN-MPHOSPH8_GPHN_chr14_66975309_ENST00000305960_MPHOSPH8_chr13_20233135_ENST00000361479_length(amino acids)=359AA_BP=24 MGNMATEGMILTNHDHQIRVGVLTDGRQQILSLGMDLQLEWMKLEDFQKHLDGKDENFAATDAIPSNVLRDAVKNGDYITVKVALNSNEE YNLDQEDSSGMTLVMLAAAGGQDDLLRLLITKGAKVNGRQKNGTTALIHAAEKNFLTTVAILLEAGAFVNVQQSNGETALMKACKRGNSD IVRLVIECGADCNILSKHQNSALHFAKQSNNVLVYDLLKNHLETLSRVAEETIKDYFEARLALLEPVFPIACHRLCEGPDFSTDFNYKPP -------------------------------------------------------------- >34257_34257_2_GPHN-MPHOSPH8_GPHN_chr14_66975309_ENST00000305960_MPHOSPH8_chr13_20233135_ENST00000414242_length(amino acids)=366AA_BP=323 MGNMATEGMILTNHDHQIRVGVLTDGRQQILSLGMDLQLEWMKLEDFQKHLDGKDENFAATDAIPSNVLRDAVKNGDYITVKVALNSNEE YNLDQEDSSGMTLVMLAAAGGQDDLLRLLITKGAKVNGRQKNGTTALIHAAEKNFLTTVAILLEAGAFVNVQQSNGETALMKACKRGNSD IVRLVIECGADCNILSKHQNSALHFAKQSNNVLVYDLLKNHLETLSRVAEETIKDYFEARLALLEPVFPIACHRLCEGPDFSTDFNYKPP QNIPEGSGILLFIFHANFLGKEVIARLCGPCSVQAVVLNDKFQLPVFLTGSRSVVQAGVQWRGLQLTGVLTSQAQAILPPQPPNYLGLKM -------------------------------------------------------------- >34257_34257_3_GPHN-MPHOSPH8_GPHN_chr14_66975309_ENST00000315266_MPHOSPH8_chr13_20233135_ENST00000361479_length(amino acids)=388AA_BP=53 MSRSPRRARSRPARSGLRFLPAPVSAVTALGNMATEGMILTNHDHQIRVGVLTDGRQQILSLGMDLQLEWMKLEDFQKHLDGKDENFAAT DAIPSNVLRDAVKNGDYITVKVALNSNEEYNLDQEDSSGMTLVMLAAAGGQDDLLRLLITKGAKVNGRQKNGTTALIHAAEKNFLTTVAI LLEAGAFVNVQQSNGETALMKACKRGNSDIVRLVIECGADCNILSKHQNSALHFAKQSNNVLVYDLLKNHLETLSRVAEETIKDYFEARL ALLEPVFPIACHRLCEGPDFSTDFNYKPPQNIPEGSGILLFIFHANFLGKEVIARLCGPCSVQAVVLNDKFQLPVFLDSHFVYSFSPVAG -------------------------------------------------------------- >34257_34257_4_GPHN-MPHOSPH8_GPHN_chr14_66975309_ENST00000315266_MPHOSPH8_chr13_20233135_ENST00000414242_length(amino acids)=396AA_BP=352 MSRSPRRARSRPARSGLRFLPAPVSAVTALGNMATEGMILTNHDHQIRVGVLTDGRQQILSLGMDLQLEWMKLEDFQKHLDGKDENFAAT DAIPSNVLRDAVKNGDYITVKVALNSNEEYNLDQEDSSGMTLVMLAAAGGQDDLLRLLITKGAKVNGRQKNGTTALIHAAEKNFLTTVAI LLEAGAFVNVQQSNGETALMKACKRGNSDIVRLVIECGADCNILSKHQNSALHFAKQSNNVLVYDLLKNHLETLSRVAEETIKDYFEARL ALLEPVFPIACHRLCEGPDFSTDFNYKPPQNIPEGSGILLFIFHANFLGKEVIARLCGPCSVQAVVLNDKFQLPVFLTGSRSVVQAGVQW -------------------------------------------------------------- >34257_34257_5_GPHN-MPHOSPH8_GPHN_chr14_66975309_ENST00000459628_MPHOSPH8_chr13_20233135_ENST00000361479_length(amino acids)=388AA_BP=53 MSRSPRRARSRPARSGLRFLPAPVSAVTALGNMATEGMILTNHDHQIRVGVLTDGRQQILSLGMDLQLEWMKLEDFQKHLDGKDENFAAT DAIPSNVLRDAVKNGDYITVKVALNSNEEYNLDQEDSSGMTLVMLAAAGGQDDLLRLLITKGAKVNGRQKNGTTALIHAAEKNFLTTVAI LLEAGAFVNVQQSNGETALMKACKRGNSDIVRLVIECGADCNILSKHQNSALHFAKQSNNVLVYDLLKNHLETLSRVAEETIKDYFEARL ALLEPVFPIACHRLCEGPDFSTDFNYKPPQNIPEGSGILLFIFHANFLGKEVIARLCGPCSVQAVVLNDKFQLPVFLDSHFVYSFSPVAG -------------------------------------------------------------- >34257_34257_6_GPHN-MPHOSPH8_GPHN_chr14_66975309_ENST00000459628_MPHOSPH8_chr13_20233135_ENST00000414242_length(amino acids)=395AA_BP=352 MSRSPRRARSRPARSGLRFLPAPVSAVTALGNMATEGMILTNHDHQIRVGVLTDGRQQILSLGMDLQLEWMKLEDFQKHLDGKDENFAAT DAIPSNVLRDAVKNGDYITVKVALNSNEEYNLDQEDSSGMTLVMLAAAGGQDDLLRLLITKGAKVNGRQKNGTTALIHAAEKNFLTTVAI LLEAGAFVNVQQSNGETALMKACKRGNSDIVRLVIECGADCNILSKHQNSALHFAKQSNNVLVYDLLKNHLETLSRVAEETIKDYFEARL ALLEPVFPIACHRLCEGPDFSTDFNYKPPQNIPEGSGILLFIFHANFLGKEVIARLCGPCSVQAVVLNDKFQLPVFLTGSRSVVQAGVQW -------------------------------------------------------------- >34257_34257_7_GPHN-MPHOSPH8_GPHN_chr14_66975309_ENST00000478722_MPHOSPH8_chr13_20233135_ENST00000361479_length(amino acids)=388AA_BP=53 MSRSPRRARSRPARSGLRFLPAPVSAVTALGNMATEGMILTNHDHQIRVGVLTDGRQQILSLGMDLQLEWMKLEDFQKHLDGKDENFAAT DAIPSNVLRDAVKNGDYITVKVALNSNEEYNLDQEDSSGMTLVMLAAAGGQDDLLRLLITKGAKVNGRQKNGTTALIHAAEKNFLTTVAI LLEAGAFVNVQQSNGETALMKACKRGNSDIVRLVIECGADCNILSKHQNSALHFAKQSNNVLVYDLLKNHLETLSRVAEETIKDYFEARL ALLEPVFPIACHRLCEGPDFSTDFNYKPPQNIPEGSGILLFIFHANFLGKEVIARLCGPCSVQAVVLNDKFQLPVFLDSHFVYSFSPVAG -------------------------------------------------------------- >34257_34257_8_GPHN-MPHOSPH8_GPHN_chr14_66975309_ENST00000478722_MPHOSPH8_chr13_20233135_ENST00000414242_length(amino acids)=396AA_BP=352 MSRSPRRARSRPARSGLRFLPAPVSAVTALGNMATEGMILTNHDHQIRVGVLTDGRQQILSLGMDLQLEWMKLEDFQKHLDGKDENFAAT DAIPSNVLRDAVKNGDYITVKVALNSNEEYNLDQEDSSGMTLVMLAAAGGQDDLLRLLITKGAKVNGRQKNGTTALIHAAEKNFLTTVAI LLEAGAFVNVQQSNGETALMKACKRGNSDIVRLVIECGADCNILSKHQNSALHFAKQSNNVLVYDLLKNHLETLSRVAEETIKDYFEARL ALLEPVFPIACHRLCEGPDFSTDFNYKPPQNIPEGSGILLFIFHANFLGKEVIARLCGPCSVQAVVLNDKFQLPVFLTGSRSVVQAGVQW -------------------------------------------------------------- >34257_34257_9_GPHN-MPHOSPH8_GPHN_chr14_66975309_ENST00000543237_MPHOSPH8_chr13_20233135_ENST00000361479_length(amino acids)=359AA_BP=24 MGNMATEGMILTNHDHQIRVGVLTDGRQQILSLGMDLQLEWMKLEDFQKHLDGKDENFAATDAIPSNVLRDAVKNGDYITVKVALNSNEE YNLDQEDSSGMTLVMLAAAGGQDDLLRLLITKGAKVNGRQKNGTTALIHAAEKNFLTTVAILLEAGAFVNVQQSNGETALMKACKRGNSD IVRLVIECGADCNILSKHQNSALHFAKQSNNVLVYDLLKNHLETLSRVAEETIKDYFEARLALLEPVFPIACHRLCEGPDFSTDFNYKPP -------------------------------------------------------------- >34257_34257_10_GPHN-MPHOSPH8_GPHN_chr14_66975309_ENST00000543237_MPHOSPH8_chr13_20233135_ENST00000414242_length(amino acids)=366AA_BP=323 MGNMATEGMILTNHDHQIRVGVLTDGRQQILSLGMDLQLEWMKLEDFQKHLDGKDENFAATDAIPSNVLRDAVKNGDYITVKVALNSNEE YNLDQEDSSGMTLVMLAAAGGQDDLLRLLITKGAKVNGRQKNGTTALIHAAEKNFLTTVAILLEAGAFVNVQQSNGETALMKACKRGNSD IVRLVIECGADCNILSKHQNSALHFAKQSNNVLVYDLLKNHLETLSRVAEETIKDYFEARLALLEPVFPIACHRLCEGPDFSTDFNYKPP QNIPEGSGILLFIFHANFLGKEVIARLCGPCSVQAVVLNDKFQLPVFLTGSRSVVQAGVQWRGLQLTGVLTSQAQAILPPQPPNYLGLKM -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr14:66975309/chr13:20233135) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| GPHN | MPHOSPH8 |
| FUNCTION: Microtubule-associated protein involved in membrane protein-cytoskeleton interactions. It is thought to anchor the inhibitory glycine receptor (GLYR) to subsynaptic microtubules (By similarity). Acts as a major instructive molecule at inhibitory synapses, where it also clusters GABA type A receptors (PubMed:25025157, PubMed:26613940). {ECO:0000250|UniProtKB:Q03555, ECO:0000269|PubMed:25025157, ECO:0000269|PubMed:26613940}.; FUNCTION: Has also a catalytic activity and catalyzes two steps in the biosynthesis of the molybdenum cofactor. In the first step, molybdopterin is adenylated. Subsequently, molybdate is inserted into adenylated molybdopterin and AMP is released. {ECO:0000269|PubMed:26613940}. | FUNCTION: Heterochromatin component that specifically recognizes and binds methylated 'Lys-9' of histone H3 (H3K9me) and promotes recruitment of proteins that mediate epigenetic repression (PubMed:20871592, PubMed:26022416). Mediates recruitment of the HUSH complex to H3K9me3 sites: the HUSH complex is recruited to genomic loci rich in H3K9me3 and is required to maintain transcriptional silencing by promoting recruitment of SETDB1, a histone methyltransferase that mediates further deposition of H3K9me3, as well as MORC2 (PubMed:26022416, PubMed:28581500). Binds H3K9me and promotes DNA methylation by recruiting DNMT3A to target CpG sites; these can be situated within the coding region of the gene (PubMed:20871592). Mediates down-regulation of CDH1 expression (PubMed:20871592). Also represses L1 retrotransposons in collaboration with MORC2 and, probably, SETDB1, the silencing is dependent of repressive epigenetic modifications, such as H3K9me3 mark. Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression (PubMed:29211708). The HUSH complex is also involved in the silencing of unintegrated retroviral DNA by being recruited by ZNF638: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (PubMed:30487602). {ECO:0000269|PubMed:20871592, ECO:0000269|PubMed:26022416, ECO:0000269|PubMed:28581500, ECO:0000269|PubMed:29211708, ECO:0000269|PubMed:30487602}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000361479 | 4 | 14 | 600_629 | 525.3333333333334 | 861.0 | Repeat | Note=ANK 1 | |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000361479 | 4 | 14 | 633_662 | 525.3333333333334 | 861.0 | Repeat | Note=ANK 2 | |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000361479 | 4 | 14 | 666_695 | 525.3333333333334 | 861.0 | Repeat | Note=ANK 3 | |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000361479 | 4 | 14 | 699_728 | 525.3333333333334 | 861.0 | Repeat | Note=ANK 4 | |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000414242 | 4 | 13 | 600_629 | 525.3333333333334 | 868.0 | Repeat | Note=ANK 1 | |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000414242 | 4 | 13 | 633_662 | 525.3333333333334 | 868.0 | Repeat | Note=ANK 2 | |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000414242 | 4 | 13 | 666_695 | 525.3333333333334 | 868.0 | Repeat | Note=ANK 3 | |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000414242 | 4 | 13 | 699_728 | 525.3333333333334 | 868.0 | Repeat | Note=ANK 4 |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | GPHN | chr14:66975309 | chr13:20233135 | ENST00000315266 | + | 1 | 22 | 14_166 | 21.333333333333332 | 737.0 | Region | Note=MPT Mo-transferase |
| Hgene | GPHN | chr14:66975309 | chr13:20233135 | ENST00000315266 | + | 1 | 22 | 326_736 | 21.333333333333332 | 737.0 | Region | Note=MPT adenylyltransferase |
| Hgene | GPHN | chr14:66975309 | chr13:20233135 | ENST00000478722 | + | 1 | 23 | 14_166 | 21.333333333333332 | 770.0 | Region | Note=MPT Mo-transferase |
| Hgene | GPHN | chr14:66975309 | chr13:20233135 | ENST00000478722 | + | 1 | 23 | 326_736 | 21.333333333333332 | 770.0 | Region | Note=MPT adenylyltransferase |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000361479 | 4 | 14 | 151_256 | 525.3333333333334 | 861.0 | Compositional bias | Note=Lys-rich | |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000414242 | 4 | 13 | 151_256 | 525.3333333333334 | 868.0 | Compositional bias | Note=Lys-rich | |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000361479 | 4 | 14 | 59_118 | 525.3333333333334 | 861.0 | Domain | Chromo | |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000414242 | 4 | 13 | 59_118 | 525.3333333333334 | 868.0 | Domain | Chromo | |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000361479 | 4 | 14 | 80_87 | 525.3333333333334 | 861.0 | Region | Histone H3K9me3 binding | |
| Tgene | MPHOSPH8 | chr14:66975309 | chr13:20233135 | ENST00000414242 | 4 | 13 | 80_87 | 525.3333333333334 | 868.0 | Region | Histone H3K9me3 binding |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| GPHN |  |
| MPHOSPH8 |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | GPHN | chr14:66975309 | chr13:20233135 | ENST00000315266 | + | 1 | 22 | 140_316 | 21.333333333333332 | 737.0 | GABARAP |
| Hgene | GPHN | chr14:66975309 | chr13:20233135 | ENST00000478722 | + | 1 | 23 | 140_316 | 21.333333333333332 | 770.0 | GABARAP |
Top |
Related Drugs to GPHN-MPHOSPH8 |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to GPHN-MPHOSPH8 |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | GPHN | C1854990 | Molybdenum Cofactor Deficiency, Complementation Group C | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Hgene | GPHN | C0001956 | Alcohol Use Disorder | 1 | CTD_human |
| Hgene | GPHN | C0001973 | Alcoholic Intoxication, Chronic | 1 | CTD_human |
| Hgene | GPHN | C0009171 | Cocaine Abuse | 1 | CTD_human |
| Hgene | GPHN | C0085762 | Alcohol abuse | 1 | CTD_human |
| Hgene | GPHN | C0236736 | Cocaine-Related Disorders | 1 | CTD_human |
| Hgene | GPHN | C0543888 | Epileptic encephalopathy | 1 | GENOMICS_ENGLAND |
| Hgene | GPHN | C0600427 | Cocaine Dependence | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies